{"id":"https://openalex.org/W7203778423","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","title":"Pharmacoeconomic evaluation of follitropin alfa in patient groups with differential ovarian response in assisted reproductive technology programs","display_name":"Pharmacoeconomic evaluation of follitropin alfa in patient groups with differential ovarian response in assisted reproductive technology programs","publication_year":2026,"publication_date":"2026-08-19","ids":{"openalex":"https://openalex.org/W7203778423","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390"},"language":"en","primary_location":{"id":"doi:10.17749/2070-4909/farmakoekonomika.2026.390","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","pdf_url":null,"source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115927380","display_name":"A. A. Slabikova","orcid":"https://orcid.org/0009-0001-7817-5180","observed_orcids":["https://orcid.org/0009-0001-7817-5180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. A. Slabikova","raw_affiliation_strings":["Center for Healthcare Quality Assessment and Control"],"raw_orcid":"https://orcid.org/0009-0001-7817-5180","affiliations":[{"raw_affiliation_string":"Center for Healthcare Quality Assessment and Control","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087998928","display_name":"\u0422. S. Teptsova","orcid":"https://orcid.org/0000-0001-5312-1007","observed_orcids":["https://orcid.org/0000-0001-5312-1007"]},"institutions":[{"id":"https://openalex.org/I4210108300","display_name":"Russian Medical Academy of Continuous Professional Education","ror":"https://ror.org/01t6bjk79","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T. S. Teptsova","raw_affiliation_strings":["Center for Healthcare Quality Assessment and Control","Russian Medical Academy of Continuing Professional Education"],"raw_orcid":"https://orcid.org/0000-0001-5312-1007","affiliations":[{"raw_affiliation_string":"Center for Healthcare Quality Assessment and Control","institution_ids":[]},{"raw_affiliation_string":"Russian Medical Academy of Continuing Professional Education","institution_ids":["https://openalex.org/I4210108300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068714046","display_name":"Vitaly Vladimirovich Omelyanovskiy","orcid":"https://orcid.org/0000-0003-1581-0703","observed_orcids":["https://orcid.org/0000-0003-1581-0703"]},"institutions":[{"id":"https://openalex.org/I4210108300","display_name":"Russian Medical Academy of Continuous Professional Education","ror":"https://ror.org/01t6bjk79","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. V. Omelyanovskiy","raw_affiliation_strings":["Center for Healthcare Quality Assessment and Control","Russian Medical Academy of Continuing Professional Education"],"raw_orcid":"https://orcid.org/0000-0003-1581-0703","affiliations":[{"raw_affiliation_string":"Center for Healthcare Quality Assessment and Control","institution_ids":[]},{"raw_affiliation_string":"Russian Medical Academy of Continuing Professional Education","institution_ids":["https://openalex.org/I4210108300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057018404","display_name":"Tatiana A. Nazarenko","orcid":"https://orcid.org/0000-0002-5823-1667","observed_orcids":["https://orcid.org/0000-0002-5823-1667","https://orcid.org/0000-0003-4414-9942"]},"institutions":[{"id":"https://openalex.org/I4210129564","display_name":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","ror":"https://ror.org/03yfnyw34","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210129564"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T. A. Nazarenko","raw_affiliation_strings":["Institute of Reproductive Medicine, Paulsen Scientific and Clinical Department of Assisted Reproductive Technologies, Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology"],"raw_orcid":"https://orcid.org/0000-0002-5823-1667","affiliations":[{"raw_affiliation_string":"Institute of Reproductive Medicine, Paulsen Scientific and Clinical Department of Assisted Reproductive Technologies, Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology","institution_ids":["https://openalex.org/I4210129564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056160401","display_name":"\u041d. \u0412. \u0411\u0430\u0448\u043c\u0430\u043a\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0001-5746-316X","observed_orcids":["https://orcid.org/0000-0001-5746-316X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. V. Bashmakova","raw_affiliation_strings":["Ural Research Institute of Maternal and Child Care"],"raw_orcid":"https://orcid.org/0000-0001-5746-316X","affiliations":[{"raw_affiliation_string":"Ural Research Institute of Maternal and Child Care","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020354150","display_name":"Dmitry V. Blinov","orcid":"https://orcid.org/0000-0002-3367-9844","observed_orcids":["https://orcid.org/0000-0002-3367-9844"]},"institutions":[{"id":"https://openalex.org/I4405263158","display_name":"Federal Scientific and Clinical Center of Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency of Russia","ror":"https://ror.org/03c1jjs85","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4405263158","https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. V. Blinov","raw_affiliation_strings":["Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency","Institute for Preventive and Social Medicine","Moscow Haass Medical Social Institute"],"raw_orcid":"https://orcid.org/0000-0002-3367-9844","affiliations":[{"raw_affiliation_string":"Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency","institution_ids":["https://openalex.org/I4405263158"]},{"raw_affiliation_string":"Institute for Preventive and Social Medicine","institution_ids":[]},{"raw_affiliation_string":"Moscow Haass Medical Social Institute","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":15000,"currency":"RUB","value_usd":142},"apc_paid":{"value":15000,"currency":"RUB","value_usd":142},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"2","first_page":"245","last_page":"255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11156","display_name":"Reproductive Health and Technologies","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11156","display_name":"Reproductive Health and Technologies","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10364","display_name":"Reproductive Biology and Fertility","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/follitropin-alfa","display_name":"follitropin alfa","score":1.0},{"id":"https://openalex.org/keywords/ovulation-induction","display_name":"ovulation induction","score":0.777999997138977},{"id":"https://openalex.org/keywords/assisted-reproductive-technology","display_name":"assisted reproduction","score":0.7350000143051147},{"id":"https://openalex.org/keywords/in-vitro-fertilization","display_name":"in vitro fertilization","score":0.9509999752044678},{"id":"https://openalex.org/keywords/infertility","display_name":"infertility","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/budget-impact-analysis","display_name":"budget impact analysis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.8259999752044678},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.8366000056266785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7907999753952026},{"id":"https://openalex.org/C2777688143","wikidata":"https://www.wikidata.org/wiki/Q179399","display_name":"Infertility","level":3,"score":0.5324000120162964},{"id":"https://openalex.org/C500014431","wikidata":"https://www.wikidata.org/wiki/Q25862","display_name":"Assisted reproductive technology","level":4,"score":0.5034000277519226},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4629000127315521},{"id":"https://openalex.org/C2776600139","wikidata":"https://www.wikidata.org/wiki/Q7113253","display_name":"Ovarian reserve","level":4,"score":0.4244999885559082},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4092999994754791},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39629998803138733},{"id":"https://openalex.org/C2779279165","wikidata":"https://www.wikidata.org/wiki/Q200774","display_name":"Follicle-stimulating hormone","level":4,"score":0.3846000134944916},{"id":"https://openalex.org/C518429986","wikidata":"https://www.wikidata.org/wiki/Q964401","display_name":"Fertility","level":3,"score":0.35429999232292175},{"id":"https://openalex.org/C2781230225","wikidata":"https://www.wikidata.org/wiki/Q3150564","display_name":"Ovulation induction","level":4,"score":0.3411000072956085},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.2718999981880188},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.26510000228881836},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2639999985694885},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.26269999146461487},{"id":"https://openalex.org/C2777702977","wikidata":"https://www.wikidata.org/wiki/Q187082","display_name":"Ovulation","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C2781065240","wikidata":"https://www.wikidata.org/wiki/Q1760461","display_name":"Ovarian hyperstimulation syndrome","level":4,"score":0.2606000006198883},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.2590999901294708},{"id":"https://openalex.org/C2778324911","wikidata":"https://www.wikidata.org/wiki/Q9631","display_name":"Ovary","level":2,"score":0.25850000977516174}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17749/2070-4909/farmakoekonomika.2026.390","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","pdf_url":null,"source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.17749/2070-4909/farmakoekonomika.2026.390","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.390","pdf_url":null,"source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W207595710","https://openalex.org/W1565160468","https://openalex.org/W1989425331","https://openalex.org/W2144601959","https://openalex.org/W2583053728","https://openalex.org/W2774074694","https://openalex.org/W2966585969","https://openalex.org/W3130990220","https://openalex.org/W4223988923","https://openalex.org/W4244325468","https://openalex.org/W4311931245","https://openalex.org/W4366829981","https://openalex.org/W4390789241","https://openalex.org/W4407744729"],"related_works":["https://openalex.org/W4366829981","https://openalex.org/W4223988923","https://openalex.org/W4235725718","https://openalex.org/W4384934902","https://openalex.org/W2805103776","https://openalex.org/W2602973290","https://openalex.org/W7135066346","https://openalex.org/W2540152885","https://openalex.org/W7213276181","https://openalex.org/W2901051660"],"abstract_inverted_index":{"Objective":[0],":":[1],"To":[2],"evaluate":[3],"the":[4,92,107,117,125,128,138,156,172,176,227,246,260],"pharmacoeconomic":[5,31],"performance":[6],"of":[7,74,87,95,110,130,148,159,186,220,233,248,263],"follitropin":[8,57,75,135,149,164,189,221,234,249,265],"alfa":[9,58,77,136,165,190,222,252,266],"in":[10,21,35,46,91,119,236],"women":[11,36,111,206],"with":[12,37,69,112,134,163,171,207,242],"poor,":[13,208],"normal,":[14,209],"and":[15,27,39,97,140,146,210],"high":[16,211],"responses":[17],"to":[18,188,197],"ovarian":[19,43,114,212],"stimulation":[20,121,132,161],"assisted":[22,268],"reproductive":[23,269],"technology":[24,270],"programs.":[25,271],"Material":[26],"methods":[28],".":[29,152,231],"A":[30,100],"evaluation":[32],"was":[33,104,166,203],"conducted":[34],"infertility":[38],"an":[40],"anticipated":[41],"poor":[42],"response":[44,115],"undergoing":[45],"vitro":[47],"fertilization,":[48],"using":[49],"a":[50,70,131,160],"cost-minimization":[51,154],"analysis.":[52],"The":[53,178],"base-case":[54],"scenario":[55],"compared":[56,127],"(Gonal-f\u00ae":[59],"\u2013":[60,66,79],"Merck":[61,80],"Serono":[62,81],"S.p.A.,":[63],"Italy;":[64],"Primapur\u00ae":[65],"IVFarma,":[67],"Russia)":[68],"fixed-dose":[71],"combination":[72],"(FDC)":[73],"alfa/lutropin":[76],"(Pergoveris\u00ae":[78],"S.A.,":[82],"Succursale":[83],"d'Aubonne,":[84],"Switzerland),":[85],"all":[86,254],"which":[88],"are":[89],"included":[90],"national":[93],"list":[94],"vital":[96],"essential":[98],"drugs.":[99],"budget":[101,179],"impact":[102,180],"analysis":[103,181],"performed":[105],"for":[106],"target":[108],"population":[109],"differential":[113],"receiving":[116],"FDC":[118,139,247],"conventional":[120],"protocols.":[122],"In":[123,153,214],"addition,":[124],"study":[126],"cost":[129,142,158,216],"cycle":[133,162],"versus":[137],"examined":[141],"differences":[143],"between":[144],"biosimilars":[145,219],"originator":[147,228],"alfa.":[150],"Results":[151],"analysis,":[155],"mean":[157],"27\u201334%":[167],"lower":[168,243],"than":[169,226,245],"that":[170,183],"FDC,":[173],"depending":[174],"on":[175],"dosage.":[177],"showed":[182],"switching":[184],"70%":[185],"patients":[187],"reduced":[191],"total":[192],"expenditures":[193],"by":[194],"30\u201333%":[195],"relative":[196],"current":[198],"practice.":[199],"This":[200],"economic":[201,261],"advantage":[202],"consistent":[204],"across":[205,253],"response.":[213],"comparative":[215],"analyses,":[217],"both":[218],"were":[223],"less":[224],"expensive":[225],"formulation.":[229],"Conclusion":[230],"Use":[232],"alfa,":[235],"particular":[237],"biosimilar":[238],"formulations,":[239],"is":[240],"associated":[241],"costs":[244],"alfa/":[250],"lutropin":[251],"evaluated":[255],"scenarios.":[256],"These":[257],"findings":[258],"support":[259],"feasibility":[262],"incorporating":[264],"into":[267]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-20T00:00:00"}